64401-08-7

Basic information

• Product Name: Benzoic acid, 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]-, 3-[2-(4-chlorophenoxy)-1-oxopropoxy]propyl ester
• CAS NO: 64401-08-7
• Molecular Formula: C29H28Cl2O8
• Molecular Weight: 575.443
• Mol File: 64401-08-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]-, 3-[2-(4-chlorophenoxy)-1-oxopropoxy]propyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]-, 3-[2-(4-chlorophenoxy)-1-oxopropoxy]propyl ester(64401-08-7)
• EPA Substance Registry System: Benzoic acid, 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]-, 3-[2-(4-chlorophenoxy)-1-oxopropoxy]propyl ester(64401-08-7)

Safety Data

• Hazardous Substances Data: 64401-08-7(Hazardous Substances Data)

Upstream product

• 3307-39-9 2-(4-chlorophenoxy)propionic acid 
• 63293-60-7 2-[2-(4-Chloro-phenoxy)-2-methyl-propionyloxy]-benzoic acid 3-hydroxy-propyl ester 
• 84370-81-0 salicylic acid hydroxypropyl ester 
• 5542-60-9 clofibryl chloride 

Relevant articles and documents

Hypolipemic activity of clofibrate related compounds. II

Clofibrate-related compounds were synthesized from substituted phenoxyacetic acids by esterification with salicylic acid derivatives, by amidation of thiazolidines or by reaction with cinnarizine. Lipid lowering effect was investigated in normolipemic and hyperlipemic rats. The long-term hyperlipemic model used permits differentiation of hypolipemic efficacy, i.e. from clofibrate or compounds of similar activity.